Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Trial details
- Registry ID
- NCT07428499
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)NCT07428499 | ADRX | Phase 3 | Recruiting | 2030-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |